Contribution of [alpha]--galactopyranosyl end groups to attachment of highly and low metastatic murine fibrosarcoma cells to various substrates by Grimstad, Ivar Amund et al.
Experimental Cell Research I55 (1984) 345-358 
Contribution of a-D-gatactopyranosyl End Groups to 
Attachment of Highly and Low Metastatic Murine 
Fibrosarcoma Cells to Various Substrates 
IVAR AMUND GRIMSTAD,*,* JAMES VARANI’ 
and J. PHILIP MCCOY, Jr.’ 
‘Department of Pathology, University of Michigan Medical School, Ann Arbor, 
MI 48109, USA and ‘Institute of Pathology, University of Oslo, 
Rikshospitalet, N-0027 Oslo 1, Norway 
There are much greater numbers of cell surface terminal, non-reducing a-n-galactorpyr- 
anosyl groups in highly malignant (metastatic) cells than are found in low malignant cells 
derived from the same murine tibrosarcoma. We have examined the contribution of these 
residues to attachment of the cells to various collagens and to plastic. Removal of these 
carbohydrate groups with a-galactosidase or blocking them with lectins from Griflonia 
simplicifofia seeds or with anti-blood group B antiserum all dramatically inhibited the 
attachment of both the highly malignant and the low malignant cells. Following removal 
with the enzyme, the a-n-galactopyranosyl end groups were rapidly resynthesized. This 
resynthesis was inhibited by tunicamycin, an inhibitor of de novo glycoprotein synthesis. 
This antibiotic also impaired cell attachment and, when used in addition to treatment with 
a-galactosidase, it inhibited cell attachment more than did treatment with the enzyme 
alone. The effects of all treatments on cell attachment were greater for the highly malignant 
than for the low malignant cells. With the latter cells, inhibition by lectin was seen only in 
the absence of serum, whereas the adhesion of highly malignant cells was affected in both 
the presence and the absence of serum. On their surface membrane the highly malignant 
cells express much more than do the low malignant cells of a glycoprotein that cross-reacts 
immunologically with laminin. The basement membrane glycoprotein laminin promotes 
cell attachment to collagen, and both glycoproteins contain terminal, non-reducing Q-D- 
galactopyranosyl groups. Attachment of cells is a requirement for the formation of a 
metastasis, and thus the laminin-like molecule and the a-n-galactopyranosyl end groups 
(whether on the laminin-related moiety or on other cell surface molecules) may both be 
important for expression of the most malignant phenotype. @ 1984 Academic press, 1~. 
In previous studies we have isolated and characterized several lines of highly 
malignant and low malignant murine fibrosarcoma cells from an uncloned tumor 
[16, 24, 25, 28, 291. The molecular basis for the differences between the highly 
and low malignant lines has not been delineated. It has recently been found, 
however, that the highly malignant cells react strongly with Griflonia simplicijb 
lia I-B4 isolectin (GSI-B4), while reactivity of the low malignant cells is not 
discernible when live cells are examined by microscopy with fluorescein isothio- 
cyanate (FITQconjugated isolectin [26]. The GS I-B4 lectin is specific for termi- 
nal, non-reducing a-D-galactopyranosyl groups [ 151. The highly malignant cells 
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are killed by complement-mediated cytotoxicity in the presence of antibodies 
requiring a-D-g&tCtOpyranOSy] end groups for binding (antibodies to human 
blood group B), while the low malignant cells are much more resistant [12, 131. 
These findings suggest that there are great differences between these cells in the 
amount of cell surface Cf-D-gZt]XtOpyrZtnOSy] end groups they express. While we 
do not know the biological importance of this difference, this is not the only 
model in which tumor cell populations with differing levels of terminal a-D- 
galactopyranosyl groups on their surface have been described. Stanley & Chu 
[20] isolated a cell line lacking a-D-g&tClOpyrEinOSy] end groups from the murine 
L-929 fibroblastic cells, which express this moiety. It was found that while the 
parent L-929 cells formed tumors upon inoculation into athymic mice, the variant 
line was non-tumorigenic. In view of these findings from two model systems 
suggesting a relationship between terminal a-D-galactopyranosyl groups and ma- 
lignancy, we have attempted to probe the relationship between the expression of 
this carbohydrate on the cell surface and the biological behavior of the cell lines. 
In this report we describe the effects of three treatments directed against the a-D- 
galactopyranosyl moieties on the ability of the fibrosarcoma cells to attach to 
collagen and plastic substrates. 
MATERIALS AND METHODS 
Cells 
We have previously isolated and characterized prototype highly malignant (l.O/Ll) and low 
malignant (l.O/anti-B’) murine fibrosarcoma cells [13, 14, 23, 24, 28, 291. 
In the present study, the cell lines were grown as monolayer cultures in RPM1 1640 medium 
supplemented with 10% fetal bovine serum at 37°C in a humidified atmosphere containing 5 % 
CO*/95 % air and subcultured by trypsinization as necessary. For use in the various assays, cells were 
harvested by brief (less than 2 min) trypsinization (Trypsin 1 : 250, Difco, Detroit, Mich.). Compared 
with harvesting by scraping, trypsinization did not alter the relative adherence or staining patterns, 
although trypsinized cells adhered rather less rapidly. Trypsinization yielded close to 100% trypan 
blue-excluding cells, whereas scraping decrreased viability. Prior to use in these studies, both cell 
types were found to be free of mycoplasma by growth in mycoplasma broth and growth on 
mycoplasma agar. 
Determination of Terminal a-D-galactopyranosyl Residues 
The presence of terminal a-D-galactopyranosyl groups on the surface of the highly malignant cells 
was demonstrated by using fluorescein isothiocyanate (FITC) conjugated GSI-B.,. This lectin has 
previously been shown to have strict specificity for terminal, non-reducing a-n-galactopyranosyl 
groups [ 151. We have described the staining procedure previously [27]. As before, binding specificity 
was always checked by using the specific hapten, methyl-a-D-galactopyranoside. In preliminary 
experiments the non-binding sugar methyl-a-o-galactopyranoside (Sigma Chemical Co.) was used in 
the same way. Fluorescence levels were determined by two investigators independently, using 
standard fluorescence microscopic techniques and coded slides, and were scored between 0 (i.e., no 
fluorescence; cells barely or not perceptible) and 4+ (intense uniform fluorescence in 100% of the 
cells). 
Adherence Assay 
Cell attachment to plastic tissue culture dishes and to collagen-coated dishes was quantified as 
described before [4, 301, with some modifications: Cells (2x10’ per dish) were plated in pre- 
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equilibrated RPM1 1640 medium supplemented as described in Results and placed in the culture 
incubator. Later, at various times, the non-attached cells were removed, and the attached cells were 
harvested with trypsin. The cells in each population were counted with a Coulter Counter, model ZB. 
During the longest incubation periods, attached cells can divide. Following incubation on uncoated 
plastic in the absence of serum, the attached cells are very resistant to trypsin. These two potential 
problems were avoided by counting only the non-attached cells in such groups. Type I collagen and 
type IV collagen were used to coat plastic dishes as previously described [26], except that 50 ug of 
collagen was deposited in each of the dishes, which were then sterilized under ultraviolet light for 2 h. 
Type I collagen prepared from mouse skin was kindly provided by Dr Sem H. Phan (Department of 
Pathology, University of Michigan). Type I collagen from rat tail (used only in the experiments in fig. 
2) and type IV collagen from human placenta [3], were from Sigma Chemical Co. 
Treatment with Enzyme and Inhibition of Protein Glycosylation 
Green coffee bean a-galactosidase (EC 3.2.1.22) was used to remove the a-D-gahCtOpyraIIOSyl 
groups from the cell surface. The enzyme was obtained from Sigma Chemical Co. Prior to its use with 
viable cells, the enzyme was tested for activity against its specific substrate (a-n-galactopyranoside) 
and against several other glycoside substrates including P-o-galactopyranoside, a-D-glucopyranoside, 
N-acetyl-j/?-n-galactosamide, N-acetyl-B-o-glucosamide, a-L-fucoside and a-n-mannoside. The p-ni- 
trophenyl derivative of each of these glycosides was used; they were purchased from Sigma Chemical 
Co. All assays were conducted at pH 6.0 in 0.05 molil phosphate buffer. A standard assay procedure 
described by Bosmann, Lockwood & Morgan [2] was used throughout, except that all of the reactions 
were carried out in a microtiter plate (final volume of 200 ~1) and the results were read using a Titertek 
Multiscan (Flow Laboratories, McLean, Va.). The stock solution of enzyme contained 42 units of 
activity per ml of buffer (3.2 molfi (NH.& SOJ. Against a-n-galactopyranoside, activity was detected 
within 30 min using 50 ~1 of a 1 : 100000 dilution of the enzyme. In contrast, no significant activity was 
detected against any of the other substrates at a 1 : 100 final dilution of the enzyme stock (largest 
amount tested). The a-galactosidase preparation was also examined for protease activity. ‘*‘I- 
hemoglobin was used as the substrate in a solid-phase protease assay, as described previously [22]. In 
50 ul of the stock enzyme, protease activity equivalent to less than 2 ng of trypsin was detected. Use 
of green coffee bean a-galactosidase from Boehringer Mannheim gave similar results. 
All treatment of cells with enzyme was done at 37°C. Treatment of cells with a-galactosidase was 
conducted at pH 6.0. Maximal enzyme activity was obtained at pH 6.0, and activity declined rapidly 
at a higher pH. Only about 25% of the maximum enzyme activity was observed at pH 6.25. 
Incubating the cells at pH 6.0 for l-2 h produced no deleterious effects, as indicated either by 
increased staining with 0.08% trypan blue or by decreased plating efficiency and growth rates in 
subsequent proliferation assays in vitro. For these studies, harvested cells were washed twice in PBS 
(pH 6.0) and incubated in PBS (pH 6.0) containing 10% fetal bovine serum and 1.2 U/ml of a- 
galactosidase. Serum was included because omission resulted in decreased cell viability at pH 6.0, 
both with and without a-galactosidase present. Normally the concentration of cells was 1-2~ 106/ml 
when treated in this way. During incubation the cells were kept in plastic tubes and maintained in 
suspension by gentle rocking. Incubation was terminated by adding a large excess of growth medium 
buffered at pH 7.2. Cells to be assayed in RPM1 1640 medium with serum were washed once in such 
medium. Cells to be assayed in other media were washed four times in the appropriate medium. 
Control cells were treated in exactly the same manner, except that they were incubated without 
enzyme. Controls at both pH 6.0 and pH 7.2 were used with each experiment. 
In some experiments, cells were treated with 0.5 ug/ml of tunicamycin (Sigma Chemical Co.), an 
inhibitor of protein glycosylation [21], alone or following treatment with a-galactosidase. When 
tunicamycin was used, it was included in the neutralization, washing and assay media. The trypan 
blue exclusion method showed that neither single nor combined treatment reduced cell viability as 
compared with when cells were kept at pH 6.0 (control) and treated with only a-galactosidase, 
respectively. We also obtained growth curves of cells that had been treated with tunicamycin (0.5 
@ml of growth medium) for 24 h. By phase contrast microscopy the cells were adherent and well 
spread prior to addition of tunicamycin. No change in their morphology was seen after treatment for 5 
h. After 24 h almost all the cells had become rounded, and some had detached from the plastic dish. 
When subsequently cultured in growth medium, the cells spread out again, and after a lag phase they 
had the same doubling time and reached the same saturation density as the control cells. 
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In certain experiments we used /?-galactosidase (EC 3.2.1.23) obtained from Sigma Chemical Co. 
(Sigma grade VIII; purified from E. cofi). The cells were harvested by brief trypsinization and 
incubated with p-galactosidase in PBS with 10% fetal bovine serum at pH 7.3, which is the optimum 
pH for this enzyme. Treatment was for 45 min, following which the cells were washed and analysed as 
following exposure to a-galactosidase. The p-nitrophenyl derivative of the specific substrate (B-D- 
galactopyranoside) was used in control experiments to check the activity of the enzyme preparation. 
a-D-Galactopyranosyl-binding Lectins and Serum 
The GS I lectin [6] was used to inhibit cell attachment. It was obtained as a gift from Dr Irwin J. 
Goldstein (Department of Biological Chemistry, University of Michigan). The GS I lectin is actually a 
mixture of five isolectins, each a tetramer composed of various combinations of the A and B subunits. 
One of these isolectins (GS I-B4) has strict specificity for terminal, non-reducing a+galactopyranosyl 
groups [15]. To confirm that the effects observed with GS I were, in fact, due to the ability of the B4 
subunit to bind a-o-galactopyranosyl groups, we used the haptenic sugar, methyl-a-o-galactopyrano- 
side, in conjunction with the lectin. Methyl-a-o-glucopyranoside served as a non-binding control 
sugar, and GS I-B4 (from Sigma Chemical Co.) was used to inhibit cell attachment in some experi- 
ments. For reasons to be described later, hyperimmune human anti-A, anti-B, and anti-A,B sera were 
also used to interfere with cell attachment. These sera were purchased from four different companies: 
Ortho Diagnostics (Raritan, N.J.); Pfizer Diagnostics (Groton, Corm.); DADE, Division of American 
Hospital Supply Corporation (Miami, Fla.) and Biological Corporation of America (West Chester, 
Pa.). 
RESULTS 
Effects of Treatment with a-Galactosidase and Tunicamycin 
on Cell Attachment 
We first examined the effects on cell attachment of treating the highly and low 
malignant cells with a-galactosidase at pH 6.0 for 45 min. After this treatment 
nearly 100% of the highly malignant cells showed no evidence of staining with 
GSI-B4. In contrast, cells maintained at pH 6.0 but not exposed to enzyme 
showed the same staining pattern as cells maintained at pH 7.2 throughout. 
Nearly 100% of the cells were positive (+3 to +4), and this staining was 
eliminated when the cells were incubated with the lectin in the presence of the 
haptenic sugar, methyl-a-D-galactopyranoside. The non-binding sugar methyl-a- 
D-glucopyranoside did not affect staining. Greater than 95 % of the cells incubat- 
ed at pH 6.0 but not exposed to the enzyme were viable as indicated by the 
trypan blue stain exclusion method. This was identical with what was observed 
with cells maintained at pH 7.2 throughout. However, the treatment with enzyme 
did produce a slight increase in the number of dead cells. We routinely observed 
that 90-95% of the cells in the enzyme-treated groups were viable. It should be 
noted that 45 min was chosen as the time of incubation of the cells with the a- 
galactosidase after carefully weighing against each other enzyme effectiveness in 
removing cell surface a-D-galactopyranosyl groups and toxicity for the cells. In 
preliminary experiments, toxicity was evaluated with similar results with the 
trypan blue staining method, plating efficiency, and growth curves in vitro. 
Treatment for 30 min produced no toxicity but did not completely remove the a- 
D-galactopyranosyl residues from the highly malignant cells, although the degree 
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B Fig. 1. Effect of treatment with a-galacto- 
sidase on attachment of highly malignant 
cells to collagen in presence of 10% fetal 
bovine serum. The cells were treated with 
the a-galactosidase and subsequently ex- 
amined for ability to attach, as described in 
Materials and Methods. Cell attachment to 
type I collagen is shown in (A) and attach- 
ment to type IV collagen in (B). Cl, a-Ga- 
lactosidase-treated cells; A, control cells 
incubated at pH 6.0, but not exposed to 
enzyme. The values shown are the means 
f SD of two independent sets of experi- 
ments, each with duplicate samples. 
Time (hours) 
of reactivity with FITC-GSI-B4 was considerably diminished relative to control 
cells. On the other hand, treatment of the cells with the a-galactosidase for 
periods longer than 45 min produced an unacceptably high number of dead cells 
(greater than 10%). The low malignant cells had no detectable surface a-D: 
galactopyranosyl end groups as indicated by fluorescence microscopy with 
FITC-GSI-B4. However, these cells must contain some of this sugar, because 
when extracts of the low malignant cells were separated by affinity chromato- 
graphy on immobilized GS I, a small amount of material was retained that could 
be eluted with methyl-a-D-galactopyranoside [26]. The low malignant cells toler- 
ated a 45min treatment with a-galactosidase just as well as the highly malignant 
cells, judged by the same criteria. 
Enzyme-treated highly malignant cells were examined for adherence to the 
collagen substrates in the presence of 10% fetal bovine serum. Fig. 1 shows that 
the enzyme-treated cells attached to both collagen types more slowly than the 
untreated control cells. Although not shown in fig. 1, the percentage of cells 
attached at 18 h was similar for both groups, indicating that the inhibition of 
attachment following treatment with enzyme was temporary. We observed (data 
not shown) that attachment to plastic dishes in the presence of 10% fetal bovine 
serum was also retarded after exposure to enzyme. Treatment of the cells with 
the a-galactosidase for 30 min inhibited attachment to plastic as well as to the 
collagen substrates. Not surprisingly, however, inhibition was not as great after 
30 min of treatment as it was after 45 min. Untreated cells maintained at pH 7.2 
throughout behaved as the control cells incubated at pH 6.0. 
Since treatment of the highly malignant cells with a-galactosidase produced 
only a transient inhibition of cell attachment, we examined how soon after 
treatment the cells regained expression of terminal a-D-gahCtOpyranOSyl groups 
as assessed by their ability to stain with FITC-GS I-B4 lectin. To do this, the cells 
were treated with enzyme in the normal manner and then replated in growth 
Exp Cell Res 155 (1984) 
350 Grimstad, Varani and McCoy Jr 
medium and allowed to attach at 37°C. At various times, the attached cells were 
reharvested with trypsin and stained. No fluorescent cells were seen at very early 
time points. Detectable staining became evident in the attached cells as early as 1 
h after the termination of treatment with enzyme. However, the staining was 
much weaker than with the cells not treated with enzyme. Essentially the same 
observations were made when, after incubation with enzyme, the cells were 
allowed to recover in suspension by rocking them gently in growth medium in 
plastic tubes at 37°C. The results of these experiments indicate that the a-D- 
galactopyranosyl residues on the cell surface and the ability to attach are both 
regained rapidly after treatment with a-galactosidase. 
In addition to resynthesis of a-D-galactopyranosyl end groups on the cell 
surface, slowly acting serum-dependent mechanisms may have contributed to the 
regaining of ability to attach. 
In further adherence experiments with a-galactosidase-treated cells, serum was 
omitted (fig. 2). Untreated cells and enzyme-treated cells were either not further 
modified or subjected to additional treatment with tunicamycin (0.5 @ml; see 
Materials and Methods), an inhibitor of protein glycosylation. Thus, control cells 
and cells treated in three different ways were compared for ability to attach to 
type I and type IV collagen substrates in the absence of serum. Fig. 2 shows that 
treatment of the highly malignant cells with a-galactosidase dramatically de- 
creased both their rate and final (after 4 h) extent of attachment to both collagens. 
Inclusion of tunicamycin following treatment with enzyme partially prevented the 
recovery of ability to attach to both collagens. However, after first reaching a 
plateau, the attachment rate did increase with time, and this increase correlated 
with the recurrence of very faint fluorescence seen when incubating with 
FITC-GSI-B4. The cells that had been treated only with enzyme regained a-~- 
galactopyranosyl groups more rapidly (data not shown). When the cells were 
treated with tunicamycin only, both the rate and the final extent of attachment to 
the collagens were decreased, but not as much as following the other two 
treatments (fig. 2). 
Similar observations concerning attachment were made with the low malignant 
cells (fig. 2). Staining of these cells in parallel was not done. However, there were 
two especially noticeable differences between the attachment characteristics of 
the highly and low malignant cells in these experiments. First, the effects of 
treatment with a-galactosidase and tunicamycin separately or combined were 
greater with the highly malignant cells. Second, the inhibitory effect of exposure 
to tunicamycin appeared earlier with the low malignant cells. 
Although no direct comparison was made of the attachment of the highly 
malignant cells in the presence and absence of serum following treatment with a- 
galactosidase, it was a reproducible finding that the inhibitory effect of the 
exposure to enzyme was clearly greater in the absence of serum. The effect of 
treatment with enzyme on the low malignant cells was tested only in the absence 
of serum. 
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Fig. 2. Effect of treatment with a-galactosidase and/or tunicamycin on the attachment of (A B) highly; 
(C, 0) low malignant cells to collagen in the absence of serum. Attachment to type I collagen is shown 
in (A) and (C), and to type IV collagen in (I?) and (D). X, Control cells; cells treated with 0, a- 
galactosidase; 0, both a-galactosidase and tunicamycin; A, with tunicamycin only. The highly 
malignant and low malignant cells were assayed on separate occasions. Values shown are means + 
SD of three independent sets of experiments, each with duplicate samples. 
In other experiments, the cells were treated with /I-galactosidase. Concentra- 
tions between 0.12 and 12 U/ml had no effect on cell viability, staining with 
FITC-GS I-B4 or attachment to a variety of substrates (data not shown). 
Inhibition of Cell Attachment by the a-D-Galactopyranosyl-binding 
Lectins GS Z and GS Z-B4 
We expected that the GSI lectin would inhibit the attachment of the highly 
malignant fibrosarcoma cells to the type I and type IV collagen substrates without 
any decline in activity with time. The results are shown in fig. 3. Whereas the 
control cells attached very rapidly to both collagen types in the presence of 
serum, the addition of GSI at 50 l&ml completely and permanently inhibited 
attachment. In the absence of serum, cell attachment to both collagen types was 
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Fig. 3. Effect of GSI lectin on the attachment of highly malignant cells to collagen. Experiments 
depicted in (A) and (B) were carried out in the presence of 10% fetal bovine serum. Experiments 
shown in (C’) and (0) were run under serum-free conditions. Cell attachment to type I collagen is 
shown in (A) and (C) and attachment to type IV collagen in (B) and (0). A, Control conditions; q , 
cultures in which 50 @ml of GS I lectin was used; 0, cultures in which 50 cLg/ml of GS I lectin was 
added at time zero and in which 50 mmohl of methyl-a-galactopyranoside was added at 4 h. The 
values shown in all panels (except for the methyl-a-n-galactopyranoside treatment) are means 3~ SD 
of three independent experiments, each with duplicate samples. Methyl-a-n-galactopyranoside was 
used in two experiments. 
slower and less complete. However, the inhibitory effects of the lectin seen in the 
absence of serum were similar in magnitude to those observed in the presence of 
serum. Dose-response studies showed that cell attachment was blocked at con- 
centrations of GSI as low as 10 ug/ml, but inhibitory activity fell away at lower 
concentrations (data not shown). The ability of methyl-a-D-galactopyranoside (50 
mmol/l) to reverse the GS I-mediated inhibition of cell attachment (fig. 3) indicat- 
ed that the effect of GSI was due to its a-D-galactopyranosyl-binding capacity. 
This also indicated that the lectin was not toxic to the cells. Further studies 
showed that the addition of 50 ug/ml GS I to cells 1 h after plating failed to release 
the already attached cells but did prevent cell spreading and caused cells that 
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Table 1. Effect of GS I-B4 lectin in combination with selected saccharides on the 
attachment of the highly malignant cells to type IV collagen-coated dishes in the 




GS I-B4, 50 &ml + 
methyl-a-D-glucopyranoside, 50 mmolil 
GSI-B,, 50 pg/ml + 




L2 Cells were harvested and counted as described in Materials and Methods at a single time point 48 h 
after plating. All values represent the means + SD of duplicate dishes in a single experiment. The 
assay was run three times. 
were already spread to become round. The GSI lectin also completely inhibited 
the attachment of the highly malignant fibrosarcoma cells to plastic cell culture 
dishes in the presence of 10% fetal bovine serum. However, the lectin had no 
effect on the even much more rapid, presumably surface charge-mediated, at- 
tachment of the cells to the plastic culture dishes that occurred in the absence of 
serum (data not shown). 
To firmly establish that the inhibition of cell attachment mediated by the 
isolectin mixture GS I was really due to its terminal a-D-galactopyranosyl-binding 
capacity and to show that inhibitory activity was retained even after prolonged 
incubation, other experiments were performed. The highly malignant cells were 
left on the type IV collagen substrate for 48 h in the absence of serum. The cells 
remained viable. Prior to addition of the cells, GS I-B4 isolectin (50 pg/ml, which 
binds specifically to a-D-g&iCtOpyranOSyl groups [15], had been added to some 
dishes along with methyl a-D-glucopyranoside (50 mmol/l) or methyl-a-o-galacto- 
pyranoside (50 mmol/l). Table 1 shows that in the presence of methyl-a-D- 
galactopyranoside, the GS I-B4 lectin had no significant effect on cell attachment. 
However, when methyl-a-D-glucopyranoside was present, the lectin greatly in- 
hibited cell attachment. Methyl-a-D-glucopyranoside by itself had no effect on 
cell attachment (data not shown). Thus, even during prolonged incubation the 
highly malignant cells did not overcome the attachment-inhibitory effect of 
specifically blocking a-D-gahCtOpyI?tnOSyl end groups. 
We also examined the effects of the GSI lectin on the attachment of the low 
malignant cells. Table 2 shows that in the presence of 10% fetal bovine serum, 
there was no significant effect on cell attachment to either of the two collagen 
substrates or plastic. By contrast, in the absence of serum, the GSI lectin 
significantly inhibited the attachment of these cells to both collagen substrates. 
Even here, however, the results were not as dramatic as those obtained with the 
highly malignant cells. Finally, we observed with the low malignant cells (as with 
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Table 2. Effect of GSI lectin on the attachment of the low malignant cells to 
plastic dishes and to collagen-coated dishes” 
Percentage of cells attached to 
Plastic 
‘Type 1 Type IV 
collagen collagen 
Serum-free 
Serum-free + 50 @ml GS I 
10% fetal bovine serum 
10% fetal bovine serum + 
50 @ml GS 1 
95fl 64+1 55+1 
95+2 28+2 34+2 
95+1 8223 77fl 
94+1 81f4 75k4 
a Cells were counted at a single point 4 h after plating. All values represent the means f SD of 
duplicate dishes in a single experiment. The assay was run twice. 
the highly malignant cells) that treatment with lectin had no effect on the very 
rapid attachment to plastic in the absence of serum. 
Inhibition of Cell Attachment by Antisera requiring a-D-galactopyranosyl 
End Groups for Binding 
The human blood group B antigen contains terminal a-D-gaktOpyranOSyl 
groups as part of its carbohydrate structure, whereas the group A antigen does 
not [32], and the human anti-blood group antibodies are directed toward the 
carbohydrate portion of the molecule [IO]. We have previously shown that sera 
with anti-blood group B specificity (i.e., anti-B and anti-A,B) react with the cells 
containing a-D-galactopyranosyl end groups on their surface [ 131. Whether these 
antibodies would affect cell adherence in vitro, however, was not known. In 
order to test this, we substituted the human hyperimmune typing sera (either anti- 
A, anti-B or anti-A,B) for fetal bovine serum in tissue culture medium and 
examined the ability of the highly malignant cells to attach to the type I and type 
IV collagen substrates. Several lots of each antiserum type (from four different 
manufacturers) were used. The results are shown in fig. 4. Although there was a 
tremendous variability from lot to lot with the anti-A sera, most of these sera 
allowed cell attachment to both collagen substrates. These antisera were exam- 
ined on 2-3 occasions with little intra-lot variability from day to day. With the 
anti-B and anti-A,B sera present, clearly fewer of the highly malignant cells 
attached to either collagen type than in the presence of most of the anti-A sera. 
The results were most dramatic when type IV collagen was used. On this 
substrate, no appreciable cell attachment occurred with any of the 13 prepara- 
tions of anti-B and anti-A,B sera present. This indicates specificity of cell 
attachment inhibition by those antisera binding to terminal a-D-galactopyranosyl- 
containing moieties. Fig. 4 also shows that cell attachment to the type IV collagen 
substrate was less than the attachment to the type I collagen. 
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Fig. 4. Attachment of highly malignant 
cells to collagen in presence of hyperim- 
mune human anti-A, anti-B, and anti-A,B 
sera. All values shown were obtained at a 
single time point, 4 h after plating the cells, 
in one single experiment. Each value repre- 
sents a different lot of the hyperimmune 
serum. Lots of each serum type were ex- 
amined on two to three occasions with little 
intra-lot variability. 0, Type I; 0, type IV 
collagen was the substrate. 
The antisera directed against blood groups had similar effects on the attach- 
ment of the low malignant cells to the collagens. The anti-B and anti-A,B sera 
were very inhibitory compared with the anti-A sera, and with all of the sera cell 
adherence was clearly less with the type IV collagen substrate than with the type 
I collagen (data not shown). 
DISCUSSION 
In this study we have demonstrated that three treatments directed toward the 
~-D-gakU3OpJZU’tOSyl end groups on the surface of murine fibrosarcoma cells 
inhibited the cells from attaching to collagen coated dishes and under some 
conditions also to plastic. These treatments included using (1) an enzyme which 
selectively cleaves the U-D-gZilaCtOpyI3IWSyl residues from the cell surface; (2) a- 
D-galactopyranosyl-binding lectins; and (3) human blood group-specific antibod- 
ies requiring a-D-galactopyranosyl groups for binding. 
When cells were treated with the coffee bean a-D-galactosidase, the decrease in 
adhesiveness was accompanied by a loss in staining with the fluorescein-labelled 
lectin specific for a-D-galactopyranosyl groups. When the cells were incubated at 
37°C in medium with 10% serum, they rapidly regained ability to stain with the 
lectin and concomitantly regained the ability to adhere to the substrate. Howev- 
er, when enzyme-treated cells were exposed to tunicamycin, both their ability to 
stain with the lectin and their ability to attach were further retarded. Tunicamycin 
inhibits de nouo synthesis of the core oligosaccharide, but allows terminal regly- 
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cosylation of a core oligosaccharide already bound to a polypeptide chain 1211. 
Limited return of a-D-galactopyranosyl end groups and ability to attach were in 
fact observed even in the presence of tunicamycin. In contrast to these results, 
the enzyme specific for P-D-galactopyranosyl groups had no effect on cell staining 
or attachment. All in all, this is solid evidence that terminal a-D-galactopyranosyl 
groups are essential for cell attachment in this system. 
The attachment experiments involving the lectins and the antibodies also 
suggested that the a-D-gahCtOpyKUIOSyl groups contribute to this cell function. 
With both agents, treatment of the highly malignant cells dramatically and 
specifically inhibited attachment to the collagen substrates. While it cannot be 
absolutely excluded that lectin and antibody, once they have bound specifically 
to the cells, are interfering with cell attachment simply by steric hindrance, the 
treatment with lectin had no effect on the ability of the cells to attach to plastic 
culture dishes in the absence of serum. 
In contrast to these results with the highly malignant cells, the same treatments 
were, taken together, much less effective with the low malignant cells. These 
cells contain far fewer surface a-D-galactopyranosyl residues than the highly 
malignant cells [14]. This suggests that mechanisms which are, at least in part, 
independent of a-D-g&iCtOpyranOSyl end groups play a greater role in the attach- 
ment of the low malignant cells than of the highly malignant cells. The existence 
of multiple attachment mechanisms in the former cells would not be surprising. 
Several studies have documented the existence of multiple attachment mechan- 
isms in various cell types [5, 7, 9, 17, 311. 
The molecular role of the terminal a-D-galactopyranosyl groups important for 
attachment of the fibrosarcoma cells to collagen remains to be determined. It is 
tempting to speculate that the existence of this sugar on the highly metastatic 
cells is due to the presence of the laminin-like moiety on these cells, since this is 
consistent with several documented facts. It is known that laminin contains 
terminal a-D-galactopyranosyl residues as part of its carbohydrate structure [18]. 
It is also known that the highly malignant cells used in this study express on their 
surface a substance which reacts with antibodies made to murine laminin [ 12, 261. 
In light of these findings it is reasonable to suggest that attachment of the highly 
malignant cells is mediated, at least in part, by the laminin-like molecule and that 
the removal of the sugar residues on this glycoprotein or the addition of lectins or 
antibodies that bind to these carbohydrate residues disrupt the molecule’s func- 
tion. Perhaps the sugar is at the active attachment site. On the other hand, it may 
be that the sugar serves to maintain the proper conformation of the molecule. 
Additional work is necessary to determine if either of these ideas is correct. It is 
also possible that the cell surface terminal a-D-galactopyranosyl residues influ- 
ence cellular adhesiveness independently of the laminin-like glycoprotein. This 
may be true particularly in the case of the low malignant cells, which do not 
express laminin-like molecules on their surface [12]. Interestingly, our recent 
studies 181 using high resolution two-dimensional electrophoresis demonstrated 
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that the protein patterns of the highly malignant and low malignant fibrosarcoma 
cells were very similar overall; only a very few differences existed. 
Several studies have shown that other sugar moieties, particularly sialic acid, 
promote cell-to-cell and/or cell-to-substrate adhesion [l, 11, 19, 331. While the 
mechanism by which sialic acid enhances adherence is not known, sialic acid 
levels (and relative adhesiveness) have been positively correlated with metastatic 
activity in murine tumor cells [34]. Thus, it seems possible that terminal a-D- 
galactopyranosyl groups and sialic acid groups may both contribute to the expres- 
sion of the malignant phenotype by promoting ability to attach. The possibility of 
such a role for the a-D-galactopyranosyl end groups is not contradicted by the 
finding that the three treatments directed against these groups all inhibited 
attachment of both the highly and low malignant cells. Although ability to adhere 
is not a sufficient condition for metastatic capacity, it is probably a necessary 
condition. These sugar groups mediated cell attachment to type I and type IV 
collagen without any consistent preference for one over the other, and under 
some conditions also to plastic, Thus, the carbohydrate group studied here may 
be part of broadly active attachment-mediating structures found in various cell 
types. 
In summary then, these studies show clearly that treatments removing or 
blocking the a-D-galactopyranosyl end groups dramatically decrease the attach- 
ment of the highly malignant murine fibrosarcoma cells to dishes coated with 
collagen of type IV (found in basement membranes) and type I (the collagen most 
widespread in interstitial tissue). This suggests that the terminal a-D-galactopyr- 
anosyl groups are involved in the attachment process, although their exact role is 
not known. The same treatments also decrease the attachment of the low malig- 
nant cells but only under particular conditions. Alternative attachment mechan- 
isms may be more important in these cells than in the highly malignant cells. The 
differences in expression of cell surface terminal a-D-galactopyranosyl groups 
and in attachment that we have found between the cell types used here may be 
related to the dissimilarity in the capacity of metastasis identified previously in 
the same cells [25, 28, 291. 
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